Kuros Biosciences AG operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kuros Biosciences AG with three other
miscellaneous service companies in Europe:
of the United Kingdom
sales of £4.52 million [US$5.50 million]
of which 51%
was Preclinical Research services),
(5.58 million Euro [US$5.94 million]
argen X BV
based in Belgium
(6.85 million Euro [US$7.29 million]
of which 63%
was Research and Development Service Fees (F).
Sales increased substantially in 2015:
During the year ended December of 2015, sales at
Kuros Biosciences AG were 6.36 million Swiss Francs (US$6.30 million).
increase of 535.5%
versus 2014, when the company's sales were 1.00 million Swiss Francs.